Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
D000818:Animals; D001775:Blood Circulation / Q000187:drug effects*; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002415:Cats; D003331:Coronary Vessels / Q000187:drug effects; D004285:Dogs; D004395:Dye Dilution Technique; D004558:Electric Stimulation; D004562:Electrocardiography; D004837:Epinephrine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010042:Ouabain / Q000633:toxicity; D011817:Rabbits; D013565:Sympatholytics / Q000494:pharmacology* / Q000633:toxicity; D014655:Vascular Resistance / Q000187:drug effects
D004983:Ethanolamines; D013565:Sympatholytics; D010042:Ouabain; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine